US Stock MarketDetailed Quotes
APTO Aptose Biosciences
- 0.1780
- -0.0062-3.37%
Close Nov 26 16:00 ET
- 0.1900
- +0.0120+6.74%
Post 19:59 ET
3.47MMarket Cap-60P/E (TTM)
0.1852High0.1703Low627.17KVolume0.1850Open0.1842Pre Close112.37KTurnover4.31%Turnover RatioLossP/E (Static)19.52MShares2.907752wk High-0.38P/B2.59MFloat Cap0.130052wk Low--Dividend TTM14.54MShs Float1457.9988Historical High--Div YieldTTM8.09%Amplitude0.1300Historical Low0.1790Avg Price1Lot Size
Aptose Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -40.37%6.97M | -49.18%7.35M | -30.76%9.76M | 22.90%52.36M | 16.57%12.13M | 16.51%11.68M | 35.41%14.45M | 22.57%14.1M | -34.91%42.6M | -57.27%10.4M |
| Selling and administrative expenses | -33.85%2.26M | -24.13%2.93M | -37.17%3.31M | 7.68%15.54M | -16.79%3M | -0.26%3.42M | 16.52%3.86M | 28.81%5.27M | -25.31%14.43M | -12.10%3.61M |
| -General and administrative expense | -33.85%2.26M | -24.13%2.93M | -37.17%3.31M | 7.68%15.54M | -16.79%3M | -0.26%3.42M | 16.52%3.86M | 28.81%5.27M | -25.31%14.43M | -12.10%3.61M |
| Research and development costs | -43.05%4.7M | -58.30%4.41M | -26.85%6.45M | 30.89%36.77M | 34.53%9.12M | 25.51%8.26M | 44.15%10.58M | 19.18%8.81M | -38.92%28.09M | -66.47%6.78M |
| Depreciation amortization depletion | -60.00%4K | -58.33%5K | -66.67%6K | -39.51%49K | -55.56%8K | -58.33%10K | -42.86%12K | 0.00%18K | -41.30%81K | -47.06%18K |
| -Depreciation and amortization | -60.00%4K | -58.33%5K | -66.67%6K | -39.51%49K | -55.56%8K | -58.33%10K | -42.86%12K | 0.00%18K | -41.30%81K | -47.06%18K |
| Operating profit | 40.37%-6.97M | 49.18%-7.35M | 30.76%-9.76M | -22.90%-52.36M | -16.57%-12.13M | -16.51%-11.68M | -35.41%-14.45M | -22.57%-14.1M | 34.91%-42.6M | 57.27%-10.4M |
| Net non-operating interest income expense | -94.83%12K | -71.47%93K | -71.33%121K | 46.07%1.15M | -57.36%171K | -8.66%232K | 193.69%326K | 1,818.18%422K | 738.30%788K | 1,722.73%401K |
| Non-operating interest income | -94.83%12K | -71.47%93K | -71.33%121K | 46.07%1.15M | -57.36%171K | -8.66%232K | 193.69%326K | 1,818.18%422K | 738.30%788K | 1,722.73%401K |
| Other net income (expense) | 50.00%-1K | 77.78%-2K | -50.00%1K | 140.00%2K | 0.00%-3K | 33.33%-2K | -800.00%-9K | 0.00%2K | ||
| Gain on sale of security | ---- | ---- | 50.00%-1K | 77.78%-2K | -50.00%1K | 140.00%2K | 0.00%-3K | 33.33%-2K | -800.00%-9K | 0.00%2K |
| Income before tax | 39.26%-6.95M | 48.67%-7.25M | 29.51%-9.64M | -22.44%-51.21M | -19.55%-11.96M | -17.08%-11.45M | -33.73%-14.13M | -19.12%-13.68M | 36.01%-41.82M | 58.89%-10M |
| Income tax | ||||||||||
| Net income | 39.26%-6.95M | 48.67%-7.25M | 29.51%-9.64M | -22.44%-51.21M | -19.55%-11.96M | -17.08%-11.45M | -33.73%-14.13M | -19.12%-13.68M | 36.01%-41.82M | 58.89%-10M |
| Net income continuous Operations | 39.26%-6.95M | 48.67%-7.25M | 29.51%-9.64M | -22.44%-51.21M | -19.55%-11.96M | -17.08%-11.45M | -33.73%-14.13M | -19.12%-13.68M | 36.01%-41.82M | 58.89%-10M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 39.26%-6.95M | 48.67%-7.25M | 29.51%-9.64M | -22.44%-51.21M | -19.55%-11.96M | -17.08%-11.45M | -33.73%-14.13M | -19.12%-13.68M | 36.01%-41.82M | 58.89%-10M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 39.26%-6.95M | 48.67%-7.25M | 29.51%-9.64M | -22.44%-51.21M | -19.55%-11.96M | -17.08%-11.45M | -33.73%-14.13M | -19.12%-13.68M | 36.01%-41.82M | 58.89%-10M |
| Basic earnings per share | 78.98%-0.37 | 81.06%-0.43 | 67.12%-0.73 | -11.47%-7.58 | 11.66%-1.44 | -10.69%-1.76 | -31.98%-2.27 | -23.33%-2.22 | 37.90%-6.8 | 59.75%-1.63 |
| Diluted earnings per share | 78.98%-0.37 | 81.06%-0.43 | 67.12%-0.73 | -11.47%-7.58 | 11.66%-1.44 | -10.69%-1.76 | -31.98%-2.27 | -23.33%-2.22 | 37.90%-6.8 | 59.75%-1.63 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data